A Double-blind Comparative Study of the Efficacy and Safety of E3810 10mg Once and Twice Daily in Maintenance Therapy for PPI Resistant Gastroesophageal Reflux Disease Patients
Clinical trial NCT02135107 · COMPLETED
Trial details
- NCT number
- NCT02135107
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2016-05-01
- Enrollment
- 517
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.